Advertisements


We are Sorry, This Page doesn't Exist


HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS

RICHMOND HILL, Ontario, March 16, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: "HBP"), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal .....»»

Category: earningsSource: benzingaMar 16th, 2020

Pan American Silver Announces Filing of 2019 Audited Annual Financial Statements and Annual Information Form

VANCOUVER, March 12, 2020 /PRNewswire/ - Pan American Silver Corp. (NASDAQ:PAAS) (TSX:PAAS) ("Pan American") has filed its 2019 audited annual financial statements and related management's discussion and analysis (the "Statemen.....»»

Category: earningsSource: benzingaMar 12th, 2020

Joint Corp. down 6% to $14.19 after disclosing material weakness in filing

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 6th, 2020

Arbutus Biopharma upgraded to Buy from Neutral at Chardan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 6th, 2020

Arbutus Biopharma Q4 results "as expected," says JMP Securities

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 5th, 2020

Arbutus Biopharma expects to complete IND-enabling studies of AB-836 by year-end

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 5th, 2020

Arbutus Biopharma expects cash to fund operations into mid-2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 5th, 2020

Arbutus Biopharma reports FY19 EPS ($2.89), consensus ($1.31)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 5th, 2020

Arbutus Biopharma pipeline driven by clinical RNAi, Baird starts with Outperform

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2020

Arbutus Biopharma initiated with an Outperform at Baird

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2020

Fluor delays 10-K filing as SEC probes financial reporting

Irving, Texas-based Fluor Corp. announced Feb. 18 that the Securities and Exchange Commission is conducting an investigation into the engineering company’s past accounting and financial reporting. The SEC is concerned with information related to proj.....»»

Category: topSource: bizjournalsFeb 19th, 2020

Arbutus Biopharma to discontinue AB-452, develop next-gen oral RNA-destabilizer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 10th, 2020

Arbutus Biopharma upgraded to Outperform from Market Perform at JMP Securities

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2020

Arbutus Biopharma price target raised to $6 from $3 at B. Riley FBR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2020

Cannabis-tech company Akerna terminated its CFO, filing shows

Akerna Corp. , a Nasdaq-traded software company aimed at the cannabis industry, terminated its chief financial officer last week, according to a filing with the Securities and Exchange Commission that arrive.....»»

Category: topSource: marketwatchDec 23rd, 2019

Arbutus Biopharma files $150M mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 23rd, 2019

E3 Metals Corp Announces Filing of Q3 2019 Financial Statements and MD&A

TSXV: ETMCFSE: OU7AOTC: EEMMF CALGARY, Nov. 29, 2019 /CNW/ - E3 METALS CORP. (TSXV:ETMC, FSE: OU7A, OTC:EEMMF) (the "Company" or "E3 Metals") announces that it has filed its Q3 2019 Financial Statements for the three and nine months ended.....»»

Category: earningsSource: benzingaNov 29th, 2019

Sugarbud Announces Financial & Operating Results for Third Quarter 2019 and Intention to be Cash Flow Positive in Third Quarter of 2020

CALGARY, Nov. 28, 2019 /CNW/ - Sugarbud Craft Growers Corp. (TSXV:SUGR, SUGR.WT, SUGR.RT)) ("Sugarbud" or the "Company") is pleased to announce the filing of its unaudited condensed consolidated interim financial statements ("Financial Statements") f.....»»

Category: earningsSource: benzingaNov 28th, 2019

Arbutus Biopharma reports Q3 EPS ($1.50), consensus (39c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 6th, 2019

Arbutus Biopharma (ABUS) Investor Presentation - Slideshow

Arbutus Biopharma (ABUS) Investor Presentation - Slideshow.....»»

Category: topSource: seekingalphaOct 8th, 2019